With family and friends by her side, Katherine Sophia (Martin) Reynolds went into a deep sleep losing her battle with ...

Alzheimer's Disease is the most common form of dementia and is a progressive condition that affects the brain, yet certain ...

For more information on the foundation and more insight into what we can all do to support those suffering from these ...

Cassava Sciences' simufilam failed a Phase III trial for Alzheimer's disease, likely marking the end of a drug surrounded by ...

Hormonal changes in women: Perimenopause and menopause cause estrogen and dopamine levels to drop in women in their 40s and ...

“For caregivers, it means creating an environment where our loved ones can feel safe, valued, and present in the moment.

Cassava Sciences' Alzheimer's drug simufilam failed key trial endpoints, leading to a stock plunge. See why SAVA stock is at risk of delisting or merger.

Elizabeth Kensinger discusses her research on the role of emotion in memory and changes in the field in an interview with APS ...

Ginkgo biloba extract — known as the “brain herb” — stems from dried leaves of the ginkgo biloba tree, which is native to ...

Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...

PORTSMOUTH, Va. (WAVY) – U.S. Senator Tim Kaine applauded the unanimous Senate passage of a bill to help combat Alzheimer’s ...

Cassava Sciences’ SAVA stock shed more than 80% of market value on Monday after the company reported that its lead pipeline ...